Close Menu

NEW YORK — Ultivue said today that it has closed a $22 million Series C round of financing.

The round was led by new investor Northpond Ventures with participation from existing investors including Arch Venture Partners, 6 Dimensions Capital, Yonghua Capital, and Applied Ventures.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.